BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16326897)

  • 21. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemophilia A and B are associated with abnormal spatial dynamics of clot growth.
    Ovanesov MV; Krasotkina JV; Ul'yanova LI; Abushinova KV; Plyushch OP; Domogatskii SP; Vorob'ev AI; Ataullakhanov FI
    Biochim Biophys Acta; 2002 Aug; 1572(1):45-57. PubMed ID: 12204332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pathway of coagulation on endothelial cells.
    Nawroth PP; Stern DM
    J Cell Biochem; 1985; 28(4):253-64. PubMed ID: 3877062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of platelet and monocyte activation for therapeutic immunoglobulin-induced thromboembolism.
    Salge-Bartels U; Heiden M; Groß N; Seitz R
    Thromb Res; 2014 Feb; 133(2):244-53. PubMed ID: 24342536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cellular model of blood coagulation process].
    Bijak M; Rzeźnicka P; Saluk J; Nowak P
    Pol Merkur Lekarski; 2015 Jul; 39(229):5-8. PubMed ID: 26277170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of pathologic clot formation: a mathematical model.
    Shavlyugin EA; Hanin LG; Khanin MA
    J Theor Biol; 2014 Jan; 340():96-104. PubMed ID: 23973916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.
    Bajaj SP; Joist JH
    Semin Thromb Hemost; 1999; 25(4):407-18. PubMed ID: 10548073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
    Mackman N; Tilley RE; Key NS
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet coagulation-protein interactions.
    Walsh PN
    Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation.
    Bouma BN; Mosnier LO; Meijers JC; Griffin JH
    Thromb Haemost; 1999 Dec; 82(6):1703-8. PubMed ID: 10613658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A kinetic model for simulation of blood coagulation and inhibition in the intrinsic path.
    Qiao YH; Liu JL; Zeng YJ
    J Med Eng Technol; 2005; 29(2):70-4. PubMed ID: 15804855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation.
    Keuren JF; Magdeleyns EJ; Govers-Riemslag JW; Lindhout T; Curvers J
    Br J Haematol; 2006 Aug; 134(3):307-13. PubMed ID: 16848773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood coagulation dynamics: mathematical modeling and stability results.
    Sequeira A; Santos RF; Bodnár T
    Math Biosci Eng; 2011 Apr; 8(2):425-43. PubMed ID: 21631138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. II. Results.
    Zarnitsina VI; Pokhilko AV; Ataullakhanov FI
    Thromb Res; 1996 Dec; 84(5):333-44. PubMed ID: 8948060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of coagulation kinetics using thromboelastometry-methodologic influence of activator and test medium.
    Sørensen B; Fenger-Eriksen C; Christiansen K; Larsen OH; Ingerslev J
    Ann Hematol; 2010 Nov; 89(11):1155-61. PubMed ID: 20480163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using microfluidics to understand the effect of spatial distribution of tissue factor on blood coagulation.
    Shen F; Kastrup CJ; Ismagilov RF
    Thromb Res; 2008; 122 Suppl 1():S27-30. PubMed ID: 18691495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into platelet-based control of coagulation.
    de Witt SM; Verdoold R; Cosemans JM; Heemskerk JW
    Thromb Res; 2014 May; 133 Suppl 2():S139-48. PubMed ID: 24862135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of phospholipids in hemostasis].
    Sletnes KE
    Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2238-41. PubMed ID: 8362386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the tissue factor pathway in initiation of coagulation.
    Mann KG; van't Veer C; Cawthern K; Butenas S
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S3-7. PubMed ID: 9819022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.